Safeguard Scientifics (NYSE:SFE) Receives New Coverage from Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of Safeguard Scientifics (NYSE:SFEGet Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the asset manager’s stock.

Safeguard Scientifics Trading Up 1.0 %

SFE opened at $1.01 on Wednesday. The firm has a market cap of $16.69 million, a price-to-earnings ratio of -1.58 and a beta of 0.93. Safeguard Scientifics has a 12 month low of $0.95 and a 12 month high of $3.80. The stock has a fifty day moving average price of $1.06 and a 200-day moving average price of $1.41.

Safeguard Scientifics (NYSE:SFEGet Free Report) last released its quarterly earnings results on Thursday, August 10th. The asset manager reported ($0.18) EPS for the quarter.

Insider Buying and Selling

In other Safeguard Scientifics news, major shareholder Thomas A. Satterfield, Jr. bought 50,000 shares of the company’s stock in a transaction that occurred on Friday, August 18th. The shares were purchased at an average cost of $1.17 per share, for a total transaction of $58,500.00. Following the purchase, the insider now directly owns 525,000 shares in the company, valued at $614,250. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 7.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Clayton Partners LLC grew its stake in Safeguard Scientifics by 15.7% during the 1st quarter. Clayton Partners LLC now owns 143,349 shares of the asset manager’s stock valued at $247,000 after purchasing an additional 19,429 shares during the last quarter. Bank of America Corp DE grew its stake in Safeguard Scientifics by 32,504.1% during the 1st quarter. Bank of America Corp DE now owns 128,786 shares of the asset manager’s stock valued at $222,000 after purchasing an additional 128,391 shares during the last quarter. Yakira Capital Management Inc. grew its stake in Safeguard Scientifics by 1.0% during the 1st quarter. Yakira Capital Management Inc. now owns 1,164,945 shares of the asset manager’s stock valued at $2,004,000 after purchasing an additional 11,200 shares during the last quarter. Legal & General Group Plc grew its stake in Safeguard Scientifics by 5.3% during the 2nd quarter. Legal & General Group Plc now owns 95,711 shares of the asset manager’s stock valued at $357,000 after purchasing an additional 4,815 shares during the last quarter. Finally, State Street Corp grew its stake in Safeguard Scientifics by 17.2% during the 2nd quarter. State Street Corp now owns 21,165 shares of the asset manager’s stock valued at $79,000 after purchasing an additional 3,111 shares during the last quarter. 44.14% of the stock is currently owned by hedge funds and other institutional investors.

Safeguard Scientifics Company Profile

(Get Free Report)

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.

Read More

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.